載入...
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin
OBJECTIVE: Our objective was to compare all-cause and stroke- and bleed-specific healthcare costs among patients with non-valvular atrial fibrillation (NVAF) treated with dabigatran or warfarin. METHODS: Administrative claims data from the MarketScan(®) Databases for 2009–2014 were used. Patients wi...
Na minha lista:
| 發表在: | Am J Cardiovasc Drugs |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5701952/ https://ncbi.nlm.nih.gov/pubmed/28795348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-017-0244-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|